Association between Two Common Polymorphisms and Risk of Hepatocellular Carcinoma: Evidence from an Updated Meta-Analysis
Table 3
Meta-analysis of the miR-196a2 C>T polymorphism associated with hepatocellular carcinoma.
Comparisons
OR
95% CI
Overall
T versus C
0.891
0.815–0.974
0.011
0.012
TT versus CC
0.783
0.649–0.943
0.010
0.007
CT versus CC
0.831
0.714–0.967
0.017
0.025
CT/TT versus CC
0.817
0.703–0.949
0.008
0.012
TT versus TC/CC
0.907
0.807
1.020
0.094
Asian
T versus C
0.910
0.837–0.990
0.029
0.036
TT versus CC
0.817
0.684–0.976
0.026
0.021
CT versus CC
0.838
0.712–0.98
0.033
0.017
CT/TT versus CC
0.833
0.712–0.974
0.022
0.012
TT versus TC/CC
0.935
0.846–1.032
0.181
0.270
: P value of Q test for heterogeneity test; OR odds: odds ratio; CI: confidence interval; random-effects model was used when ; otherwise, fix-effects model was used.
